T1	PROC 324 349	TRATAMIENTO CON HIERRO IV
T2	CHEM 340 346	HIERRO
#1	AnnotatorNotes T2	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T3	PROC 366 378	HEMODIÁLISIS
#2	AnnotatorNotes T3	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T4	DISO 470 476	Anemia
#3	AnnotatorNotes T4	C0002871; Anemia; Disease or Syndrome
T5	PROC 493 505	hemodiálisis
#4	AnnotatorNotes T5	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T6	DISO 575 581	anemia
#5	AnnotatorNotes T6	C0002871; Anemia; Disease or Syndrome
T7	PROC 585 597	hemodiálisis
#6	AnnotatorNotes T7	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T8	PROC 662 674	hemodiálisis
#7	AnnotatorNotes T8	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T9	PROC 698 726	tratamiento con hemodiálisis
#8	AnnotatorNotes T9	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T10	PROC 818 842	consentimiento informado
#9	AnnotatorNotes T10	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T11	PROC 749 761	hemodiálisis
#10	AnnotatorNotes T11	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T12	DISO 860 866	anemia
#11	AnnotatorNotes T12	C0002871; Anemia; Disease or Syndrome
T13	CHEM 898 904	hierro
#12	AnnotatorNotes T13	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T14	CHEM 931 937	hierro
#13	AnnotatorNotes T14	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T15	PROC 963 975	hemodiálisis
#14	AnnotatorNotes T15	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T16	CHEM 1086 1098	transferrina
#15	AnnotatorNotes T16	C0040679; Transferrin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T17	CHEM 1172 1181	ferritina
#16	AnnotatorNotes T17	C0015879; Ferritin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T18	CHEM 1248 1254	hierro
#17	AnnotatorNotes T18	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T19	PROC 1280 1292	hemodiálisis
#18	AnnotatorNotes T19	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T20	DISO 1361 1392	infección crónica por VHC y VHB
T21	PROC 46 73	Ensayo clínico aleatorizado
#19	AnnotatorNotes T21	C0206034; Clinical Trials, Randomized; Research Activity
T22	PROC 91 127	administración de hierro intravenoso
T23	CHEM 109 115	hierro
#20	AnnotatorNotes T23	C0302583; iron; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T24	PROC 151 167	práctica clínica
T25	PROC 235 262	ENSAYO CLÍNICO ALEATORIZADO
#21	AnnotatorNotes T25	C0206034; Clinical Trials, Randomized; Research Activity
T26	PROC 394 410	PRÁCTICA CLÍNICA
T27	PROC 886 909	tratada con hierro i.v.
T28	PROC 1075 1098	niveles de transferrina
T29	PROC 1101 1109	albúmina
#22	AnnotatorNotes T29	C0201838; Albumin measurement; Laboratory Procedure
T30	PROC 1161 1181	niveles de ferritina
#23	AnnotatorNotes T30	C0373607; Ferritin measurement; Laboratory Procedure
T31	Date 13 17	2019
T32	Route 116 127	intravenoso
#24	AnnotatorNotes T32	C1522726; Intravenous Route of Drug Administration; Functional Concept
T34	Route 347 349	IV
#25	AnnotatorNotes T34	C1522726; Intravenous Route of Drug Administration; Functional Concept
T35	LIVB 353 362	PACIENTES
#26	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 438 446	EXPERTOS
#27	AnnotatorNotes T36	C1706750; Agent Expert; Professional or Occupational Group
T37	LIVB 480 489	pacientes
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 561 570	pacientes
#29	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 626 635	Pacientes
#30	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	Duration 680 694	más de 2 meses
T41	Duration 729 745	menos de 6 meses
T42	Age 781 797	mayor de 18 años
T43	LIVB 846 855	Pacientes
#31	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Spec_cue 867 878	susceptible
T45	Route 905 909	i.v.
#32	AnnotatorNotes T45	C1522726; Intravenous Route of Drug Administration; Functional Concept
T46	Neg_cue 913 915	No
T47	Route 938 942	i.v.
#33	AnnotatorNotes T47	C1522726; Intravenous Route of Drug Administration; Functional Concept
T48	LIVB 979 988	Pacientes
#34	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Duration 1040 1057	superior a 2 años
T50	LIVB 1061 1070	Pacientes
#35	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 1147 1156	Pacientes
#36	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T53	LIVB 1219 1228	Pacientes
#37	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Route 1255 1259	i.v.
#38	AnnotatorNotes T54	C1522726; Intravenous Route of Drug Administration; Functional Concept
T55	LIVB 1296 1343	Pacientes embarazadas o en período de lactancia
#39	AnnotatorNotes T55	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T56	LIVB 1347 1356	Pacientes
#40	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Duration 1371 1378	crónica
#41	AnnotatorNotes T57	C0205191; chronic; Temporal Concept
T58	LIVB 1383 1386	VHC
#42	AnnotatorNotes T58	C0220847; hepatitis C virus; Virus
T59	LIVB 1389 1392	VHB
#43	AnnotatorNotes T59	C0019169; hepatitis B virus; Virus
T60	PHYS 1306 1317	embarazadas
#44	AnnotatorNotes T60	C0032961; Pregnancy; Organism Function
T33	LIVB 203 211	expertos
#45	AnnotatorNotes T33	C1706750; Agent Expert; Professional or Occupational Group
T61	PHYS 532 557	Funcionalidad monocitaria
#46	AnnotatorNotes T61	C0312842; Monocyte production; Organ or Tissue Function (?)
T62	PHYS 279 304	FUNCIONALIDAD MONOCITARIA
#47	AnnotatorNotes T62	C0312842; Monocyte production; Organ or Tissue Function (?)
T52	PHYS 1334 1343	lactancia
#48	AnnotatorNotes T52	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A1	Assertion T27 Speculated
A2	Assertion T13 Speculated
A4	Assertion T14 Negated
A3	Status T14 History_of
A5	Status T18 History_of
#49	AnnotatorNotes T28	C0202105; Transferrin measurement; Laboratory Procedure 
#50	AnnotatorNotes T20	C0524910; Hepatitis C, Chronic; Disease or Syndrome + C0524909; Hepatitis B, Chronic; Disease or Syndrome
A6	Assertion T45 Speculated
A7	Status T47 History_of
A8	Status T54 History_of
R1	Speculation Arg1:T44 Arg2:T27	
R2	Speculation Arg1:T44 Arg2:T13	
R3	Speculation Arg1:T44 Arg2:T45	
A9	Assertion T47 Negated
R4	Negation Arg1:T46 Arg2:T14	
R5	Negation Arg1:T46 Arg2:T47	
R6	Used_for Arg1:T23 Arg2:T22	
T63	CONC 419 434	RECOMENDACIONES
#51	AnnotatorNotes T63	C0034866; Recommendation; Idea or Concept
T64	CONC 184 199	recomendaciones
#52	AnnotatorNotes T64	C0034866; Recommendation; Idea or Concept
T65	CONC 142 167	guías de práctica clínica
#53	AnnotatorNotes T65	C0282451; Clinical Practice Guideline; Intellectual Product
T66	CONC 385 410	GUÍAS DE PRÁCTICA CLÍNICA
#54	AnnotatorNotes T66	C0282451; Clinical Practice Guideline; Intellectual Product
R7	Has_Route_or_Mode Arg1:T2 Arg2:T34	
R8	Used_for Arg1:T2 Arg2:T1	
R9	Has_Route_or_Mode Arg1:T23 Arg2:T32	
R10	Experiences Arg1:T35 Arg2:T62	
R11	Experiences Arg1:T35 Arg2:T1	
R12	Experiences Arg1:T35 Arg2:T3	
R13	Overlap Arg1:T1 Arg2:T3	
R16	Experiences Arg1:T37 Arg2:T4	
R17	Experiences Arg1:T37 Arg2:T5	
R19	Experiences Arg1:T38 Arg2:T61	
R20	Experiences Arg1:T38 Arg2:T6	
R21	Experiences Arg1:T38 Arg2:T7	
R25	Experiences Arg1:T39 Arg2:T8	
R26	Has_Duration_or_Interval Arg1:T8 Arg2:T40	
R27	Has_Duration_or_Interval Arg1:T9 Arg2:T40	
R28	Has_Duration_or_Interval Arg1:T11 Arg2:T41	
R29	Experiences Arg1:T39 Arg2:T11	
T67	Quantifier_or_Qualifier 762 771	mantenida
#55	AnnotatorNotes T67	C0443318; Sustained; Functional Concept
R30	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T67	
R31	Experiences Arg1:T39 Arg2:T9	
R32	Experiences Arg1:T43 Arg2:T12	
R33	Used_for Arg1:T13 Arg2:T27	
R34	Has_Route_or_Mode Arg1:T13 Arg2:T45	
R35	Experiences Arg1:T43 Arg2:T27	
R36	Before Arg1:T14 Arg2:T15	
R37	Has_Route_or_Mode Arg1:T14 Arg2:T47	
T68	CONC 1020 1039	expectativa de vida
#56	AnnotatorNotes T68	C0023671; Life Expectancy; Group Attribute
R38	Has_Duration_or_Interval Arg1:T68 Arg2:T49	
T69	Observation 989 1010	clínicamente estables
#57	AnnotatorNotes T69	C1282982; Patient's condition stable; Finding
R39	Experiences Arg1:T48 Arg2:T69	
R40	Experiences Arg1:T50 Arg2:T28	
R41	Experiences Arg1:T50 Arg2:T29	
T70	Result_or_Value 1110 1118	normales
#58	AnnotatorNotes T70	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R42	Has_Result_or_Value Arg1:T29 Arg2:T70	
R43	Has_Result_or_Value Arg1:T28 Arg2:T70	
T71	Result_or_Value 1182 1192	>800 mg/dl
R44	Has_Result_or_Value Arg1:T30 Arg2:T71	
R45	Experiences Arg1:T51 Arg2:T30	
T72	CONC 1196 1214	inicio del estudio
#59	AnnotatorNotes T72	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R46	Overlap Arg1:T30 Arg2:T72	
R47	Before Arg1:T18 Arg2:T19	
R48	Has_Route_or_Mode Arg1:T18 Arg2:T54	
R49	Experiences Arg1:T53 Arg2:T18	
R50	Experiences Arg1:T55 Arg2:T60	
R51	Experiences Arg1:T55 Arg2:T52	
R52	Experiences Arg1:T56 Arg2:T20	
R53	Has_Duration_or_Interval Arg1:T20 Arg2:T57	
R54	Causes Arg1:T58 Arg2:T20	
R55	Causes Arg1:T59 Arg2:T20	
#60	AnnotatorNotes T22	C4733157; intravenous iron therapy; Therapeutic or Preventive Procedure
#61	AnnotatorNotes T1	C4733157; intravenous iron therapy; Therapeutic or Preventive Procedure
#62	AnnotatorNotes T27	C4733157; intravenous iron therapy; Therapeutic or Preventive Procedure
A10	Experiencer T33 Other
A11	Experiencer T35 Patient
A12	Experiencer T36 Other
A13	Experiencer T37 Patient
A14	Experiencer T38 Patient
A15	Experiencer T39 Patient
A16	Experiencer T43 Patient
A17	Experiencer T48 Patient
A18	Experiencer T50 Patient
A19	Experiencer T51 Patient
A20	Experiencer T53 Patient
A21	Experiencer T55 Patient
A22	Experiencer T56 Patient
